newsfilter
← Latest News
GlobeNewswire·

Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

HUNTSVILLE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ("Serina" or the "Company") (NYSE:SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug ("IND")